Tsunenori Kondo

18PUBLICATIONS
28CO-AUTHORS
French languageCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer diagnosisRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 10, 2026
Standardizing Upper Abdominal Fascial Terminology: A Transdisciplinary Expert Consensus From the Japanese Society for Endoscopic Surgery.

|May 07, 2026
Comparison of clinical outcomes of cabozantinib plus nivolumab and lenvatinib plus pembrolizumab in patients with metastatic renal cell carcinoma.

|Apr 30, 2026
Editorial Comment to Real-World Effectiveness and Safety of Pembrolizumab-Lenvatinib Versus Axitinib-Based Regimens in Metastatic Clear Cell Renal Cell Carcinoma: A Multicenter Retrospective Study.

|Apr 30, 2026
Editorial Comment to the Impact of the Relevant Factors as High-Complexity Tumors in Robot-Assisted Partial Nephrectomy.

|Mar 02, 2026
Real-world outcomes of third-line systemic therapy after immune checkpoint inhibitor combinations and subsequent VEGFR-TKIs in advanced renal cell carcinoma.

Hiroki Ishihara, Koichi Nishimura, Yuki Nemoto

|Jan 27, 2026
Non-Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors.

Hiroki Ishihara, Yu-Yu Liu, Riu Yamashita

Pageof 3

Frequent Collaborators

8 joint publications

Toshio Takagi

7 joint publications

Kazuhiko Yoshida

7 joint publications

Hiroki Ishihara

2 joint publications

Yudai Ishiyama